Post on 23-Jun-2020
Gynecologic Health A Novel Laser Therapy
MLTU-PPPT-A-R2
Become Yourself Again
Gynecologic Health A Novel Laser Therapy
MLTU-PPPT-A-R2
• “It” refers to changes in gynecologic health and it happens to a majority of women.
• As many as 50% of 64 million women are suffering from changes in their gynecologic health 1,2,3
MLTU-PPPT-A-R2
• Gentle fractional CO2 laser therapy
• Clinically proven to bring lasting relief
• Thousands of women successfully treated since 2012
• Overwhelmingly positive and immediate results
Because now you can do something about it.
MLTU-PPPT-A-R2
The reason for talking about the MonaLisa Touch.
Minimal side effects No downtime Lasting results
MLTU-PPPT-A-R2
Simple and Safe The MonaLisa Touch difference matters.
3 treatments of less than 5 minutes each
In-office procedure
Requires no anesthesia
Thousands of women successfully treated since 2012
MLTU-PPPT-A-R2
2 out of 4 Postmenopausal
Women are suffering from changes in their gynecologic health.
But they don’t have to.
1,2,3
as many as
MLTU-PPPT-A-R2
Clinically Proven to bring lasting relief.
A study was done by Dr. Stefano Salvatore*, Department of Obstetrics and Gynecology, Vita- Salute San Raffaele University to assess the feasibility of fractional C02 laser in the treatment of 50 women suffering changes in their gynecologic health. • Overwhelmingly positive and immediate results
• Highly statistically significant improvement in symptoms after first treatment
• 42 patients (84%) showed significant improvement in their physical and mental quality of life scores over baseline and were satisfied with the treatment. Gynecologic symptoms were significantly improved.
SOURCE: Study done in conjunction with doctors: R.E. Nappi, N. Zerbinati, A.Calligaro, S. Ferrero, M. Origoni, M. Candiani, U. Leone
Roberti MaggioreMLTU-PPPT-A-R2
Simple and Safe The MonaLisa Touch difference matters.
Virtually
MLTU-PPPT-A-R2
It’s OK to talk about it and become yourself again.
SOURCES 1 US Census, 2010 2 The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9):888-902 3 Gass ML, Cochrane BB, Larson JC, et al. Patterns and predictors of sexual health activity among women in the hormone therapy trials of the Women’s Health Initiative. Menopause. 2011:18(11):1160-1171
MLTU-PPPT-A-R2